» Articles » PMID: 37527470

Predictors of Severity of Influenza-Related Hospitalizations: Results From the Global Influenza Hospital Surveillance Network (GIHSN)

Abstract

Background: The Global Influenza Hospital Surveillance Network (GIHSN) has since 2012 provided patient-level data on severe influenza-like-illnesses from >100 participating clinical sites worldwide based on a core protocol and consistent case definitions.

Methods: We used multivariable logistic regression to assess the risk of intensive care unit admission, mechanical ventilation, and in-hospital death among hospitalized patients with influenza and explored the role of patient-level covariates and country income level.

Results: The data set included 73 121 patients hospitalized with respiratory illness in 22 countries, including 15 660 with laboratory-confirmed influenza. After adjusting for patient-level covariates we found a 7-fold increase in the risk of influenza-related intensive care unit admission in lower middle-income countries (LMICs), compared with high-income countries (P = .01). The risk of mechanical ventilation and in-hospital death also increased by 4-fold in LMICs, though these differences were not statistically significant. We also find that influenza mortality increased significantly with older age and number of comorbid conditions. Across all severity outcomes studied and after controlling for patient characteristics, infection with influenza A/H1N1pdm09 was more severe than with A/H3N2.

Conclusions: Our study provides new information on influenza severity in underresourced populations, particularly those in LMICs.

Citing Articles

Severity Scale of Influenza and Acute Respiratory Illness Hospitalizations to Support Viral Genomic Surveillance: A Global Influenza Hospital Surveillance Network Pilot Study.

Boudewijns B, Caini S, Riccio M, Nunes M, Chaves S, Andrew M Influenza Other Respir Viruses. 2025; 19(3):e70085.

PMID: 40045898 PMC: 11883289. DOI: 10.1111/irv.70085.


Antigenic Divergence from the Seasonal Vaccine of the Influenza Virus Strains Circulating in Romania During Three Successive Seasons (2021-2024).

Vlaicu O, Banica L, Hohan R, Surleac M, Florea D, Miron V Microorganisms. 2024; 12(11).

PMID: 39597751 PMC: 11596464. DOI: 10.3390/microorganisms12112363.


Age, comorbidity burden and late presentation are significant predictors of hospitalization length and acute respiratory failure in patients with influenza.

Miron V, Sandulescu O, Streinu-Cercel A, Florea D, Paraschiv S, Banica L Sci Rep. 2024; 14(1):15563.

PMID: 38971866 PMC: 11227496. DOI: 10.1038/s41598-024-66550-8.


The Impact of Obesity on the Host-Pathogen Interaction with Influenza Viruses - Novel Insights: Narrative Review.

Miron V, Draganescu A, Pitigoi D, Arama V, Streinu-Cercel A, Sandulescu O Diabetes Metab Syndr Obes. 2024; 17:769-777.

PMID: 38371386 PMC: 10874191. DOI: 10.2147/DMSO.S434115.

References
1.
Agha R, Avner J . Delayed Seasonal RSV Surge Observed During the COVID-19 Pandemic. Pediatrics. 2021; 148(3). DOI: 10.1542/peds.2021-052089. View

2.
Salluh J, Burghi G, Haniffa R . Intensive care for COVID-19 in low- and middle-income countries: research opportunities and challenges. Intensive Care Med. 2020; 47(2):226-229. PMC: 7661330. DOI: 10.1007/s00134-020-06285-y. View

3.
Shi T, McAllister D, OBrien K, Simoes E, Madhi S, Gessner B . Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in young children in 2015: a systematic review and modelling study. Lancet. 2017; 390(10098):946-958. PMC: 5592248. DOI: 10.1016/S0140-6736(17)30938-8. View

4.
Puig-Barbera J, Burtseva E, Yu H, Cowling B, Badur S, Kyncl J . Influenza epidemiology and influenza vaccine effectiveness during the 2014-2015 season: annual report from the Global Influenza Hospital Surveillance Network. BMC Public Health. 2016; 16 Suppl 1:757. PMC: 5001209. DOI: 10.1186/s12889-016-3378-1. View

5.
Ortiz J, Neuzil K . Influenza Immunization in Low- and Middle-Income Countries: Preparing for Next-Generation Influenza Vaccines. J Infect Dis. 2019; 219(Suppl_1):S97-S106. DOI: 10.1093/infdis/jiz024. View